title: Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits.
abstract: Virus-like particles (VLPs) are non-infectious subviral protein complexes, which possess structural features identical or closely related to infectious virions. They are utilized as delivery tools for immunologically relevant antigenic sequences. In order to investigate whether mutant subunits can modulate the VLP immunogenicity, comparative immunization studies with wild-type and non-native VLPs were performed. To determine whether disulfide bonding impacts on the immunogenicity of hepatitis B virus envelope proteins (HBsAg), mutant HBsAg subunits with single, double and triple cysteine residue substitutions were generated. The mutant proteins were expressed in cell culture, secretion competent non-native VLPs generated, followed by immunization studies in mice to measure the cellular immune response. The reduced ability of mutant HBsAg proteins to form disulfide bonds does not interfere with their ability to assemble into secretion competent VLPs. Depending on specific cysteine to alanine changes, VLPs could be generated with or without an increased ratio of monomeric versus dimeric/oligomeric subunits compared to wild-type VLPs. The utilization of non-native VLPs resulted in enhanced cellular immune responses and does not seem to depend on the ratio between monomeric or dimeric/oligomeric subunits. Comparative immunization studies strongly indicate that changes in the disulfide bonding modulate the VLP immunogenicity most likely due to structural changes. We hypothesize that structural features have evolved with reduced immunogenicity to evade the constraints imposed by the immune system. Altering VLP conformation may represent an attractive strategy to modulate antigen processing resulting in an enhanced immune response and/or a changed hierarchy of epitope presentation.
authors.affiliation: Department of Microbiology, Wellington Road, Clayton Campus, Bldg. 76, Monash University, Victoria 3800, Australia.
authors.forename: Wan-Shoo
authors.initials: WS
authors.lastname: Cheong
authors.affiliation: Department of Microbiology, Wellington Road, Clayton Campus, Bldg. 76, Monash University, Victoria 3800, Australia.
authors.forename: Michiko
authors.initials: M
authors.lastname: Hyakumura
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia.
authors.forename: Lilly
authors.initials: L
authors.lastname: Yuen
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia.
authors.forename: Nadia
authors.initials: N
authors.lastname: Warner
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia.
authors.forename: Stephen
authors.initials: S
authors.lastname: Locarnini
authors.affiliation: Department of Microbiology, Wellington Road, Clayton Campus, Bldg. 76, Monash University, Victoria 3800, Australia. Electronic address: hans.netter@monash.edu.
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Netter
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D002460:Cell Line; D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D006515:Hepatitis B virus / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007114:Immunization; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D014771:Virion / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D019065:Virus Assembly
chemical_list: D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines